oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Symibace

Taking into account test results showing a significant exceedance of the specification limit for impurity B content, the risk to human health from leaving these medicinal product batches on the market is real and probable. Potential effects: toxicity, adverse reactions, therapeutic complications.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Symibace
Risk Level
High
Manufacturer
Symphar sp. z o.o. z siedzibą w Warszawie
Batch Number
14S012A
EAN Code
05909990734580
Recall Date
25.01.2024
View official statement

Important Information

What You Should Know

Recommendations

Do not use Symibace tablets from the specified batches. Check the batch number on the packaging and, if you have the product, return it to the pharmacy or consult a doctor.

Actions Taken

The Symibace batches 28C012A (2.5 mg) and 14S012A (5 mg) were withdrawn from the market nationwide and their placing on the market was prohibited, with the decision given immediate enforceability.

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: Taking into account test results showing a significant exceedance of the specification limit for impurity B content, the risk to human health from leaving these medicinal product batches on the market is real and probable. Potential effects: toxicity, adverse reactions, therapeutic complications.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: 14S012A

Related

Other Recalled Products